Webinar on
Novel COVID-19 & Infectious Diseases
Theme: Novel remedy systems for COVID-19 and Infectious disorder Prevention, control and fix
Dates: July 27, 2021 Venue: London, UK
Meetings International Conferences provides opportunities, revealing oodles of unique ways you can reach your prospects through our many events and offerings.
We invite you to explore our agenda and discover the many ways you can partner, sponsor and advertise with us.
We at Meetings Int. provide direct exposure for your products and brand.
Meetings International is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Our conferences provide opportunities, revealing oodles of unique ways you can reach your prospects through our many events and offerings. It will give you the chance to listen to different points of view and learn new ideas and trends in your field and also pave the way for scientific cooperation by meeting and connecting with researchers from different countries.
Contact Sponsorship Sales Manager or email him/her at sponsor@meetingsint.com & contact@meetingsint.com with "Sponsorship Enquiry" in the subject line.
(* Please note that sponsorship opportunities are limited due to the educational-led focus of this event. Please enquire for availability.)
Webinar on Novel COVID-19 & Infectious Diseases is organizing an outstanding Scientific Program, Exhibition and anticipates the world's leading specialists involved in.
Novel COVID-19 organizing committee anticipates over 200 participants to attend this premier event. Your organization will benefit with excellent exposure to the leaders in Disease.
Novel COVID-19 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.
Novel COVID-19 is supported by the worldwide Editorial Board Members of Journal of Immunological Techniques & Infectious Diseases, Journal of Infectious Diseases & Immune Therapies and Journal of Clinical Images and Case Reports. have agreed to promote and support the event